The Jordanian Pharmaceutical Manufacturing Co. PLC announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was JOD 4.456 million compared to JOD 4.515 million a year ago. Net loss was JOD 4.805 million compared to net income of JOD 284,393 a year ago. Basic loss per share from continuing operations was JOD 0.19 compared to basic earnings per share from continuing operations of JOD 0.011 a year ago. For the nine months, sales was JOD 10.342 million compared to JOD 7.228 million a year ago. Net loss was JOD 8.618 million compared to JOD 3.448 million a year ago. Basic loss per share from continuing operations was JOD 0.34 compared to JOD 0.136 a year ago.